Additional costs of lactose-reduced diets Lactose-free dairy product substitutes are a cost-effective alternative for people with lactose intolerance

2021 ◽  
pp. 1-29
Author(s):  
Mareike Taeger ◽  
Silke Thiele

Abstract Objective People with lactose intolerance have to limit their consumption of lactose-containing dairy products which are a main source of calcium. In particular for low income people it is of interest which alternative diet form rich in calcium leads to the lowest additional costs. This study aims to calculate the additional costs of lactose-reduced diets and to show which of different options represent the most cost-effective alternative within a lactose-reduced diet. Design Using Linear Programming food baskets with different lactose contents were calculated and were compared to a basic-model, reflecting a normal diet without a limitation of lactose. By comparing the costs and the composition of the food baskets, recommendations for a lactose-reduced diet were derived. Setting Germany Participants A consumer panel dataset representative for Germany is used for the calculations. Information on prices and nutrients are derived from the 9,429 adult households without children, information on consumed food quantities from the 3,046 single households. Results The minimum additional food costs depend on the severity of lactose intolerance and range from 0.2 % to 6.1 % per month. It was found that the greatest adjustments due to lactose reduction could be observed within the dairy product group. In this group, with a rising lactose limit, normal milk was increasingly replaced by lactose-free milk. Conclusion It was shown that a lactose-reduced diet is generally associated with higher food costs. When suffering from lactose intolerance switching to lactose-free milk seems to be the most cost-effective way to cover nutrient requirements.

2017 ◽  
Vol 2 (4) ◽  
pp. 163-170 ◽  
Author(s):  
Aditi Bhatt ◽  
Robin Prabhu ◽  
Kayomarz Sethna ◽  
Sajin Tharayil ◽  
Madhan Kumar

AbstractBackgroundHIPEC using custom-made machines (CMM) remains unaffordable for many patients in low-income countries. We describe the assembly and use homemade HIPEC machine (HMM) as a cost-effective alternative.MethodsWe evaluated the cost of setting up the HMM, maintenance, expenses per procedure as well as technical aspects including target temperature and flow rate, safety aspects, technical failures and the technical support required. The comparison with CMM was based on the manufacturer information and published reports and not on personal experience.ResultsForm 2011 to 2017, we performed HIPEC (Coliseum technique) in 81 patients using HMM. HMM was a cardiopulmonary bypass machine available in our institution, with an additional water bath. Flow rate was 2 L/min and target temperature between 41 and 43 °C could be achieved in all cases. There were no technical failures and there was no safety issue recorded. Routine maintenance was provided yearly by an in-house technician. Chemotherapy costs (between 20 and 500 USD) were independent from the devices used. Cost of consumables was 450 USD/procedure, as compared to 1800 to 3500 USD/procedure for commercially available products. Investment cost for CMM is between 70,000 and 1,35,000 USD.ConclusionsThe HMM is a cost-effective option allowing access to HIPEC to patients in low-resource countries without loss of efficacy or additional safety concerns. The initial cost and cost per procedure were substantially less for HMM while the maintenance of both systems was similar in terms of complexity and cost. The CMM are more user-friendly and require less technical support.


Alloy Digest ◽  
2009 ◽  
Vol 58 (11) ◽  

Abstract Ancorsteel 4300 alloy ferrous powder simulates wrought steel compositions and is a cost-effective alternative to alloys requiring secondary processing. This datasheet provides information on composition, physical properties, hardness, and tensile properties as well as fracture toughness. It also includes information on heat treating and powder metal forms. Filing Code: SA-611. Producer or source: Hoeganaes Corporation.


HPB ◽  
2020 ◽  
Vol 22 ◽  
pp. S186-S187
Author(s):  
J. Hawksworth ◽  
N.P. Llore ◽  
M.L. Holzner ◽  
P. Radkani ◽  
E. Mesler ◽  
...  

Author(s):  
Venkatesh Piradi ◽  
Feng Yan ◽  
Xunjin Zhu ◽  
Wai-Yeung Raymond Wong

Organic solar cells (OSCs) have been considered as a promising cost-effective alternative to silicon-based solar cell counterparts due to their lightweight, mechanical flexibility, and easy fabrication features. Over the past...


2007 ◽  
Vol 17 (11) ◽  
pp. 1482-1486 ◽  
Author(s):  
Roger Noun ◽  
Eddy Riachi ◽  
Smart Zeidan ◽  
Bassam Abboud ◽  
Viviane Chalhoub ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document